Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Senitzer

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Bone Marrow Transplantation|June 9, 2009
Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHDR Rodriguez, A Nademanee, J M Palmer, et al.
Journal of Applied Genetics|October 31, 2009
Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortionI Nowak, A Malinowski, H Tchorzewski, et al.
Bone Marrow Transplantation|September 25, 2012
A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplantS K Khaled, J Palmer, T Stiller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2003
Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failedH C Fung, S Cohen, R Rodriguez, et al.
Bone Marrow Transplantation|April 6, 2004
Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignanciesR Rodriguez, P Parker, A Nademanee, et al.
Bone Marrow Transplantation|June 24, 2014
Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1K Fleischhauer, M A Fernandez-Viña, T Wang, et al.
Bone Marrow Transplantation|June 9, 2016
Impact of KIR/HLA genetic combinations on double umbilical cord blood transplantation outcomes. Results of a French multicentric retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI)P Rettman, F Malard, N Legrand, et al.
Tissue Antigens|March 21, 2013
Common and well-documented HLA alleles: 2012 update to the CWD catalogueS J Mack, P Cano, J A Hollenbach, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Bone Marrow Transplantation|June 9, 2009
Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHDR Rodriguez, A Nademanee, J M Palmer, et al.
Journal of Applied Genetics|October 31, 2009
Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortionI Nowak, A Malinowski, H Tchorzewski, et al.
Bone Marrow Transplantation|September 25, 2012
A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplantS K Khaled, J Palmer, T Stiller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2003
Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failedH C Fung, S Cohen, R Rodriguez, et al.
Bone Marrow Transplantation|April 6, 2004
Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignanciesR Rodriguez, P Parker, A Nademanee, et al.
Bone Marrow Transplantation|June 24, 2014
Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1K Fleischhauer, M A Fernandez-Viña, T Wang, et al.
Bone Marrow Transplantation|June 9, 2016
Impact of KIR/HLA genetic combinations on double umbilical cord blood transplantation outcomes. Results of a French multicentric retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI)P Rettman, F Malard, N Legrand, et al.
Tissue Antigens|March 21, 2013
Common and well-documented HLA alleles: 2012 update to the CWD catalogueS J Mack, P Cano, J A Hollenbach, et al.
Pageof 6